NEC contributes to development of artificial DNA aptamer that binds to the novel coronavirus (SARS-CoV-2) Kumar Jeetendra | May 6, 2021 India, May 6, 2021 – NEC Corporation (NEC; TSE: 6701) and NEC Solution Innovators today announced the successful development of artificial DNA aptamers (*1) that bind to the novel coronavirus (SARS-CoV-2). This breakthrough stems from the NEC Group’s efforts to promote spatial monitoring business using aptamers, including the development of new biosensing systems, such as …
